Cargando…

Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification

BACKGROUND: Osteoporosis (OP) is a major and growing public health problem characterized by decreased bone mineral density and destroyed bone microarchitecture. Previous studies found that Lycium Chinense Mill (LC) has a potent role in inhibiting bone loss. Kukoamine A (KuA), a bioactive compound ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Liying, Guan, Zhiyuan, Jin, Xiao, Guan, Zhiqiang, Jiang, Yanyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029210/ https://www.ncbi.nlm.nih.gov/pubmed/36941586 http://dx.doi.org/10.1186/s10020-023-00625-6

Ejemplares similares

Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
por: Luo, Liying, et al.
Publicado: (2023)

Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors
por: Zaragoza-Huesca, David, et al.
Publicado: (2022)

Investigation of anti-osteoporosis mechanisms of Rehmanniae Radix Preparata based on network pharmacology and experimental verification
por: Ou, Li, et al.
Publicado: (2021)

The Role of Depletion of Gut Microbiota in Osteoporosis and Osteoarthritis: A Narrative Review
por: Guan, Zhiyuan, et al.
Publicado: (2022)

Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology
por: Liang, Guihong, et al.
Publicado: (2022)

Anti-Osteoporotic Effects of Kukoamine B Isolated from Lycii Radicis Cortex Extract on Osteoblast and Osteoclast Cells and Ovariectomized Osteoporosis Model Mice
por: Park, Eunkuk, et al.
Publicado: (2019)

Prediction of Targets of Curculigoside A in Osteoporosis and Rheumatoid Arthritis Using Network Pharmacology and Experimental Verification
por: Han, Jiawen, et al.
Publicado: (2020)

Identification of Diagnostic Genes and Effective Drugs Associated with Osteoporosis Treatment by Single-Cell RNA-Seq Analysis and Network Pharmacology
por: Zhang, Zhanyue, et al.
Publicado: (2022)

A Metabolomics Approach to Investigate Kukoamine B—A Potent Natural Product With Anti-diabetic Properties
por: Li, Yuan-Yuan, et al.
Publicado: (2019)

Study on the Mechanism of Compound Kidney-Invigorating Granule for Osteoporosis based on Network Pharmacology and Experimental Verification
por: Lv, Hao, et al.
Publicado: (2022)

Using network pharmacology and molecular docking verification to explore the mechanism of ursolic acid in the treatment of osteoporosis
por: Yang, Bowen, et al.
Publicado: (2022)

Exploring the role and mechanism of Fuzi decoction in the treatment of osteoporosis by integrating network pharmacology and experimental verification
por: Li, Fudong, et al.
Publicado: (2023)

Identification of Ferroptosis-Related Genes as Biomarkers for Sarcoma
por: Guan, Zhiyuan, et al.
Publicado: (2022)

Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes
por: Yang, Dong, et al.
Publicado: (2016)

Antioxidant and Cytoprotective Effects of Kukoamines A and B: Comparison and Positional Isomeric Effect
por: Li, Xican, et al.
Publicado: (2018)

A study on the anti-osteoporosis mechanism of isopsoralen based on network pharmacology and molecular experiments
por: Wang, Jian, et al.
Publicado: (2023)

Influence of oral administration of kukoamine A on blood pressure in a rat hypertension model
por: Butts, Christine A., et al.
Publicado: (2022)

Quality control of Lycium chinense and Lycium barbarum cortex (Digupi) by HPLC using kukoamines as markers
por: Li, Yuan-Yuan, et al.
Publicado: (2017)

The gut microbiota metabolite capsiate regulate SLC2A1 expression by targeting HIF‐1α to inhibit knee osteoarthritis‐induced ferroptosis
por: Guan, Zhiyuan, et al.
Publicado: (2023)

Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network pharmacology and molecular docking
por: Tianyu, Zhao, et al.
Publicado: (2021)

Integrating network pharmacology and experimental verification strategies to reveal the active ingredients and molecular mechanism of Tenghuang Jiangu Capsule against osteoporosis
por: Li, Miao, et al.
Publicado: (2023)

Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients
por: Wang, Huanhuan, et al.
Publicado: (2021)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

The cardioprotective effects and mechanisms of naringenin in myocardial ischemia based on network pharmacology and experiment verification
por: Yang, Yakun, et al.
Publicado: (2022)

Prediction of Rhizoma Drynariae Targets in the Treatment of Osteoarthritis Based on Network Pharmacology and Experimental Verification
por: Chen, Guang-yao, et al.
Publicado: (2021)

Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4
por: To, Kwang-Il, et al.
Publicado: (2022)

Network Pharmacology Prediction and Pharmacological Verification Mechanism of Yeju Jiangya Decoction on Hypertension
por: Wang, Ting, et al.
Publicado: (2021)

Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition
por: Li, Xin, et al.
Publicado: (2020)

Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome
por: Xing, Jinshan, et al.
Publicado: (2023)

Demethylzeylasteral reduces the level of proteinuria in diabetic nephropathy: Screening of network pharmacology and verification by animal experiment
por: Xu, Lengnan, et al.
Publicado: (2022)

Study on complications of osteoporosis based on network pharmacology
por: Song, Zhijing, et al.
Publicado: (2022)

Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis
por: Fan, Jiashuang, et al.
Publicado: (2022)

Analysis of the Anti-Tumour Effect of Xuefu Zhuyu Decoction Based on Network Pharmacology and Experimental Verification in Drosophila
por: Wang, Sitong, et al.
Publicado: (2022)

Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis
por: Huang, Ann Yehong, et al.
Publicado: (2022)

Identification and verification of effective components of Huanghuai for dysfunctional uterine bleeding based on network pharmacology and molecular docking
por: Yao, Yun-xiu, et al.
Publicado: (2020)

Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
por: Zhou, Xiaohui, et al.
Publicado: (2021)

Predicting and Exploring the Mechanisms of Erzhi Pill in Prevention and Treatment of Osteoporosis Based on Network Pharmacology and Zebrafish Experiments
por: Zhong, Zhiguo, et al.
Publicado: (2021)

Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)
por: Yang, Xiaobing, et al.
Publicado: (2023)

Kukoamine A inhibits human glioblastoma cell growth and migration through apoptosis induction and epithelial-mesenchymal transition attenuation
por: Wang, Qiaoping, et al.
Publicado: (2016)

Kukoamine A Improves Mycoplasma pneumoniae Pneumonia by Regulating miR-222-3p/Superoxide Dismutase 2
por: Liu, Xiu-Xiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kp6956fs1q5m96g5drhmfb5pld